A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Columnist Betty Vertin hopes her family's experience with kidney stones might help you be better prepared while living with DMD.

Chronic back pain is often misdiagnosed as a musculoskeletal issue, when in fact, kidney stones may be the hidden cause .

Artemis Bayandor from Illinois in the US lost over a stone after starting to take game-changing weight-loss jabs, but like ...

Yes, kidney stones can cause gastrointestinal (GI) problems, such as bloating, diarrhea, and constipation. This article ...

It is estimated that around 23 percent of patients with kidney disease are prescribed cinacalcet in the US ... Higher calcium ...

In total, 331,590 bottles of Cinacalcet tablets manufactured by Dr. Reddy's Laboratories, Inc. have been recalled due to ...

Facilitated Clearance of Residual Kidney Stone Fragments vs Observation. Journal of Urology ... Advisory Board Asha Therapeutics (Asha), a life sciences company pioneering breakthrough therapeutics ...

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

Dr. Crivelli’s proposal aims to study how social factors and diet influence the risk of kidney stones in diverse populations.

People with chronic kidney disease (CKD), Type 2 diabetes, or both were predicted to have elevated cardiovascular disease ...